These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14586193)

  • 1. Women's drug injection practices in East Harlem: an event analysis in a high-risk community.
    Tortu S; McMahon JM; Hamid R; Neaigus A
    AIDS Behav; 2003 Sep; 7(3):317-28. PubMed ID: 14586193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in injection risk behaviors at the first injection episode.
    Frajzyngier V; Neaigus A; Gyarmathy VA; Miller M; Friedman SR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):145-52. PubMed ID: 17276623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City.
    Diaz T; Des Jarlais DC; Vlahov D; Perlis TE; Edwards V; Friedman SR; Rockwell R; Hoover D; Williams IT; Monterroso ER
    Am J Public Health; 2001 Jan; 91(1):23-30. PubMed ID: 11189819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in HIV and HCV Risk Behaviors and Prevalent Infection Among People Who Inject Drugs in New York City, 2005-2012.
    Neaigus A; Reilly KH; Jenness SM; Hagan H; Wendel T; Gelpi-Acosta C; Marshall DM
    J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3(Suppl 3):S325-S332. PubMed ID: 28604434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City.
    Des Jarlais DC; Diaz T; Perlis T; Vlahov D; Maslow C; Latka M; Rockwell R; Edwards V; Friedman SR; Monterroso E; Williams I; Garfein RS
    Am J Epidemiol; 2003 Mar; 157(5):467-71. PubMed ID: 12615611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
    Shapatava E; Nelson KE; Tsertsvadze T; del Rio C
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
    Vassilev ZP; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais DC
    Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada.
    Wylie JL; Shah L; Jolly AM
    BMC Public Health; 2006 Sep; 6():229. PubMed ID: 16970811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner city women.
    Feldman JG; Minkoff H; Landesman S; Dehovitz J
    Sex Transm Dis; 2000 Jul; 27(6):338-42. PubMed ID: 10907909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program.
    Månsson AS; Moestrup T; Nordenfelt E; Widell A
    Scand J Infect Dis; 2000; 32(3):253-8. PubMed ID: 10879594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.
    Des Jarlais DC; Perlis T; Arasteh K; Torian LV; Hagan H; Beatrice S; Smith L; Wethers J; Milliken J; Mildvan D; Yancovitz S; Friedman SR
    AIDS; 2005 Oct; 19 Suppl 3():S20-5. PubMed ID: 16251819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unsafe injecting practices among attendees of syringe exchange programmes in France.
    Valenciano M; Emmanuelli J; Lert F
    Addiction; 2001 Apr; 96(4):597-606. PubMed ID: 11300963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users.
    Novelli LA; Sherman SG; Havens JR; Strathdee SA; Sapun M
    Drug Alcohol Depend; 2005 Mar; 77(3):303-9. PubMed ID: 15734230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's injection drug practices in their own words: a qualitative study.
    Tuchman E
    Harm Reduct J; 2015 Mar; 12():6. PubMed ID: 25889492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.